Open AccessCosts of Treatment in Patients With Moderate to Severe Plaque Psoriasis
Author(s) -
Brent C. Opmeer,
Vera M. R. Heydendael,
Corianne A.J.M. de Borgie,
Phyllis I. Spuls,
Patrick M. Bossuyt,
Jan D. Bos,
Menno A. de Rie
Publication year - 2004
Publication title -
archives of dermatology
Language(s) - English
Resource type - Journals
eISSN - 1538-3652
pISSN - 0003-987X
DOI - 10.1001/archderm.140.6.685
Subject(s) - medicine , methotrexate , psoriasis , indirect costs , medical costs , total cost , randomized controlled trial , cumulative dose , intensive care medicine , health care , surgery , emergency medicine , dermatology , accounting , economics , business , microeconomics , economic growth
To document and compare the costs of treatment of psoriasis with 2 established systemic agents that differ substantially in their unit costs: methotrexate vs cyclosporine.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom